Clinical Trials Directory

Trials / Unknown

UnknownNCT01949753

Influence of Pregnenolone on Exposure Therapy in Obsessive-compulsive Disorder

Influence of Pregnenolone on Distress and Autonomic Parameters During Cognitive-behavioral Exposure Therapy in Patients With Obsessive-compulsive Disorder

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Universitätsklinikum Hamburg-Eppendorf · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Characterization of the influence of pregnenolone vs. placebo on subjective distress and autonomic functioning during cognitive-behavioral exposure therapy in patients with obsessive-compulsive disorder.

Detailed description

Main out-come parameters: Inter-session habituation as per SUD (100 mm VAS), Y-BOCS Secondary out-come parameter: HF/LF of HRV, Salivary epinephrine

Conditions

Interventions

TypeNameDescription
BEHAVIORALExposure therapy with pharmacological facilitationExposure with response prevention and pharmacological facilitation
BEHAVIORALExposure therapyExposure with response prevention without pharmacological facilitation

Timeline

Start date
2013-09-01
Primary completion
2017-12-01
Completion
2018-12-01
First posted
2013-09-24
Last updated
2017-08-03

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01949753. Inclusion in this directory is not an endorsement.